Normal view MARC view ISBD view

Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia.

Tvito, Ariella

Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemia. [electronic resource] - Expert opinion on biological therapy 12 2017 - 1557-1564 p. digital

Publication Type: Journal Article; Review

ISSN: 1744-7682

Standard No.: 10.1080/14712598.2017.1387244 doi

Subjects--Topical Terms:
Antibodies, Monoclonal, Humanized--chemistry
Antineoplastic Agents--chemistry
Clinical Trials as Topic
Half-Life
Humans
Immunoconjugates--therapeutic use
Inotuzumab Ozogamicin
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Prognosis

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)